Taipei, Feb. 14 (CNA) Taiwan's Food and Drug Administration (FDA) on Friday issued a product warning for the weight loss drug Belviq, after American medical authorities reported on Thursday that clinical trials on the drug's active ingredient, lorcaserin, showed an increased risk of several types of cancer.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Trace levels of radiation found in mushroom powder imported from Japan
12/05/2023 03:21 PM - Business
Taiwan shares close down 0.54%
12/05/2023 02:34 PM - Politics
Taiwan opens 4th representative office in Canada
12/05/2023 02:25 PM - Society
Chinese snack prompts concerns over young students' health, nutrition
12/05/2023 02:01 PM - Cross-Strait
Two new Chinese satellites no danger to Taiwan: Defense ministry
12/05/2023 01:04 PM